Y-90 Radioembolization for Patients with...

Dr. Reni Butler speaks with Dr. Bryan Haslam, Dr. Greg Sorensen, Dr. Matt McCabe, and Dr. Christoph Lee about their large real-world study evaluating an AI driven workflow for screening mammography across 109 U.S. facilities. Together, they explore how AI helped general radiologi ... Show More

Host Dr. Linda Chu sits down with Dr. Jie Nguyen, Dr. Todd Lawrence, and Dr. Kirk Davis to discuss an interdisciplinary consensus on standardized knee meniscus MRI reporting and the terminology that improves communication between radiologists and orthopedic surgeons. Together, th ... Show More

Dr. Ashwin Parihar speaks with Dr. Olayinka A. Abiodun-Ojo and Dr. David M. Schuster about findings from the EMPIRE 2 trial, exploring how fluciclovine PET and PSMA PET influence salvage radiotherapy planning for men with recurrent prostate cancer after prostatectomy. The discuss ... Show More

Join experts Drs Benjamin Schlechter and Diane Saverese as they discuss systemic therapy for advanced colorectal cancer. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/988974). The topics and discussions are planned ... Show More

<p>This week, we are joined by Dr. Nina Sanford, Assistant Professor and Chief of Gastrointestinal Radiation Oncology Service, UT Southwestern Medical Center in Dallas, Texas, for a discussion about the role of radiation in colorectal cancer, with an emphasis on the role of radia ... Show More

<p>This week, we incorporate medical oncology back into our discussion with our Radiation Oncologist, Dr. Sanford, and our Surgical Oncologist, Dr. Bailey. We discuss how we approach the management of localized rectal cancer. Note that we will be heavily building off our discussi ... Show More

Join Drs Benjamin Schlechter and Joshua Smith as they discuss the evolution of nonoperative rectal cancer management and organ preservation, highlighting groundbreaking trials like OPRA and JANUS. Relevant disclosures can be found with the episode show notes on Medscape https://w ... Show More

Join Drs Benjamin Schlechter and Jeff Meyerhardt as they discuss the latest breakthroughs in adjuvant chemo for CRC and share their decision-making in real-world scenarios. Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarti ... Show More

<p>This week, we are joined by Dr. Christina Bailey, Associate Professor of Surgery and Program Director of the General Surgery Residency at Vanderbilt University Medical Center in Nashville, Tennessee, for a discussion about the role of surgery in the management of patients with ... Show More

<p>This week, we continue our discussion of colorectal cancer, turning our attention to metastatic disease, specifically for cancers without targetable mutations. If you have not done already, we highly recommend you check out episode 104 for our GI oncology pharmacology discussi ... Show More

An interview with Dr. Van Morris from The University of Texas MD Anderson Cancer Center in Houston, TX and Dr. Cathy Eng from Vanderbilt-Ingram Cancer Center in Nashville, TN, co-chairs on "Treatment of Metastatic Colorectal Cancer: ASCO Guideline." Dr. Morris and Dr. Eng review ... Show More

You have a patient who underwent local excision of a rectal cancer. Final pathology demonstrates a T2 lesion. What is the rate of local recurrence? Is excision alone sufficient? Should the patient undergo radical resection or should chemoradiation be offered? Tune in to find out! ... Show More

<p>This week, we round out our discussion on metastatic colorectal cancer, focusing on more targeted therapies for this disease. If you have not done so already, be sure to check out episode 107 for the first part of our metastatic colorectal cancer discussion.</p><p>Contents: </ ... Show More